Onconetix (ONCO) News Today $3.44 -0.13 (-3.64%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$3.64 +0.21 (+5.96%) As of 07/18/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONCO Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Onconetix, Inc. (NASDAQ: ONCO)July 17 at 12:15 PM | globenewswire.comOnconetix, Inc.: Onconetix and Ocuvex Therapeutics announce execution of definitive merger agreementJuly 16 at 4:23 PM | finanznachrichten.deOnconetix Shares Touch All-Time Low on Reverse Merger With OcuvexJuly 16 at 4:23 PM | marketwatch.comONCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Onconetix, Inc. Is Fair to ShareholdersJuly 16 at 10:38 AM | businesswire.comOnconetix and Ocuvex Therapeutics announce execution of definitive merger agreementJuly 16 at 8:17 AM | globenewswire.comOnconetix, Inc. Announces Positive Decision by Nasdaq Hearings PanelJune 16, 2025 | globenewswire.comOnconetix (NASDAQ:ONCO) Trading Down 24.9% - Should You Sell?June 14, 2025 | marketbeat.comOnconetix (NASDAQ:ONCO) Rating Increased to Hold at Wall Street ZenJune 14, 2025 | marketbeat.comOnconetix, Inc. (NASDAQ:ONCO) Short Interest UpdateJune 13, 2025 | marketbeat.comOnconetix, Inc. Announces Approval of 1-for-85 Reverse Stock Split by StockholdersJune 13, 2025 | nasdaq.comOnconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of StockholdersJune 11, 2025 | globenewswire.comOnconetix faces potential Nasdaq delisting over filing delaysMay 24, 2025 | investing.comOnconetix receives additional delisting notice from NasdaqMay 23, 2025 | finance.yahoo.comOnconetix, Inc. Announces Receipt of Additional Notice from NasdaqMay 22, 2025 | globenewswire.comOnco-Innovations Uplists to Cboe CanadaMay 22, 2025 | businesswire.comOnconetix, Inc. Announces Receipt of Additional Notice from NasdaqApril 30, 2025 | globenewswire.comOnconetix faces third delisting threat since 2022 IPOApril 21, 2025 | bizjournals.comOnconetix Inks Letter Of Intent For Potential Business Combination With OcuvexApril 10, 2025 | nasdaq.comFive things you need to know today, and calming irrational fearsApril 9, 2025 | bizjournals.comOnconetix signs non-binding LOI for potential combination with OcuvexApril 9, 2025 | markets.businessinsider.comCincinnati's Onconetix pursuing merger deal with drug development firmApril 8, 2025 | bizjournals.comOnconetix Signs Letter of Intent for Potential Business Combination with Ocuvex Therapeutics, Inc.April 8, 2025 | markets.businessinsider.com🌱 Cincinnati's arena debate heats upApril 6, 2025 | msn.comOnconetix executive chairman resigns in latest leadership exit; interim CFO named new top leaderApril 5, 2025 | bizjournals.comOnconetix Names Interim CFO Karina Fedasz as Interim CEOApril 3, 2025 | marketwatch.comOnconetix claims validation of prostate cancer test Proclarix in Danish cohortMarch 25, 2025 | finance.yahoo.comOnconetix Announces Successful Clinical Validation of its Innovative Prostate Cancer Test Proclarix in a Danish cohortMarch 24, 2025 | globenewswire.comOnconetix, Inc. to Present Proclarix Study Results at 2025 EAU Congress in MadridMarch 21, 2025 | nasdaq.comOnconetix announces new clinical data for Proclarix to be presented at EAUMarch 21, 2025 | markets.businessinsider.comOnconetix Announces New Clinical Data for its Innovative Prostate Cancer Test Proclarix Accepted for Presentation at 2025 European Association of Urology CongressMarch 19, 2025 | globenewswire.comOnconetix names new executive chairman, appoints board memberMarch 2, 2025 | investing.comOnconetix files to sell 50M shares of common stock for holdersJanuary 27, 2025 | msn.comOnconetix faces Nasdaq delisting over share price ruleJanuary 24, 2025 | msn.comOnconetix settles with IQVIA, adjusts accounts payableJanuary 22, 2025 | msn.comOnconetix, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q and Subsequent FilingDecember 12, 2024 | globenewswire.comOnconetix files to sell 10.59M shares of common stock for holdersNovember 1, 2024 | markets.businessinsider.comOnconetix, Inc. (NASDAQ:ONCO) Sees Large Decline in Short InterestOctober 25, 2024 | marketbeat.comOnconetix, Inc. (NASDAQ:ONCO) Sees Significant Increase in Short InterestOctober 10, 2024 | marketbeat.comCorrection: Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditOctober 3, 2024 | globenewswire.comOnconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of CreditOctober 3, 2024 | globenewswire.comWhat's Going On With Onconetix Shares Friday?September 28, 2024 | msn.comUnited States shares higher at close of trade; Dow Jones Industrial Average up 0.20%September 24, 2024 | msn.comOnconetix, Inc. (J4T.MU)September 24, 2024 | nz.finance.yahoo.comOnconetix, Inc. (J4T.F)September 24, 2024 | nz.finance.yahoo.comOnconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of StockholdersSeptember 20, 2024 | globenewswire.comOnconetix (NASDAQ:ONCO) Stock, Short Interest ReportJuly 19, 2024 | benzinga.comOnconetix (NASDAQ:ONCO) Stock Quotes, Forecast and News SummaryJuly 19, 2024 | benzinga.comWhy Is Onconetix (ONCO) Stock Up 37% Today?July 18, 2024 | investorplace.comOnconetix Announces Closing of Warrant Exercise for $1.11 Million Gross ProceedsJuly 15, 2024 | globenewswire.comOnconetix Announces Exercise of Warrants for $1.11 Million Gross ProceedsJuly 11, 2024 | globenewswire.com Get Onconetix News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCO and its competitors with MarketBeat's FREE daily newsletter. Email Address ONCO Media Mentions By Week ONCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCO News Sentiment▼0.010.57▲Average Medical News Sentiment ONCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCO Articles This Week▼60▲ONCO Articles Average Week Get Onconetix News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNSE News GNPX News ADXN News IXHL News MBRX News KPRX News DWTX News AEON News APRE News TLPH News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCO) was last updated on 7/19/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Onconetix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Onconetix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
